Skip to main content

Animations

MJFF Publications

3481 - 3490 of 6516 Results
Title
Year
  • Year
  • 2016
  • 2024
  • 2017
  • 2018
  • 2012
  • 2024
  • 2024
  • 2018
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease
    Journal Name: Cell Stem Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.stem.2016.08.002
    Citation Count: 464
  • Summary Details
    OPEN
    Title: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29902
    Citation Count: 38
  • Summary Details
    OPEN
    Title: The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1
    Journal Name: ChemBioChem
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/cbic.201700500
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Optical Structural Analysis of Individual α‐Synuclein Oligomers
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ange.201710779
    Citation Count: 0
  • Summary Details
    OPEN
    Title: GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182735e9a
    Citation Count: 155
  • Summary Details
    OPEN
    Title: Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 Isoforms
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.4c00029
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00716-z
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The Luxembourg Parkinson’s Study: A Comprehensive Approach for Stratification and Early Diagnosis
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2018.00326
    Citation Count: 97
  • Summary Details
    OPEN
    Title: White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2018.00163
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Alterations of Brain Structural Network in Parkinson’s Disease With and Without Rapid Eye Movement Sleep Behavior Disorder
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2018.00334
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.